Rights and permissions
About this article
Cite this article
Gefitinib effective for patients with NSCLC and mutations in the EGFR gene. Inpharma Wkly. 1547, 15 (2006). https://doi.org/10.2165/00128413-200615470-00038
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615470-00038